Cargando…
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
Mismanagement of bacterial infection therapies has undermined the reliability and efficacy of antibiotic treatments, producing a profound crisis of the antibiotic drug market. It is by now clear that tackling deadly infections demands novel strategies not only based on the mere toxicity of anti-infe...
Autores principales: | Puccetti, Matteo, Xiroudaki, Styliani, Ricci, Maurizio, Giovagnoli, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408102/ https://www.ncbi.nlm.nih.gov/pubmed/32635461 http://dx.doi.org/10.3390/pharmaceutics12070624 |
Ejemplares similares
-
Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives
por: Xiroudaki, Styliani, et al.
Publicado: (2021) -
Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics
por: Puccetti, Matteo, et al.
Publicado: (2021) -
Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?
por: Puccetti, Matteo, et al.
Publicado: (2023) -
Tryptophan as a Central Hub for Host/Microbial Symbiosis
por: Borghi, Monica, et al.
Publicado: (2020) -
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
por: Puccetti, Matteo, et al.
Publicado: (2022)